Patents by Inventor Larry David Ward

Larry David Ward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for screening for soluble ligands to a receptor-type tyrosine kinase
    Patent number: 6599709
    Abstract: The present invention relates to a method of screening for ligands to a receptor-type tyrosine kinase. The receptor-type tyrosine, in its naturally occurring form, is characterized by being reactive to monoclonal antibody III.A4, having an apparent molecular weight of approximately 120-150 kD in its glycosylated form, and having the N-terminal amino acid sequence E L I P Q P.
    Type: Grant
    Filed: November 18, 1999
    Date of Patent: July 29, 2003
    Assignee: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Andrew W. Boyd, Richard Simpson, Ian Wicks, Larry David Ward, David Wilkinson
  • Receptor-type tyrosine kinase and use thereof
    Patent number: 6020306
    Abstract: The present invention relates to an isolated receptor-type tyrosine kinase. The receptor-type tyrosine, in its naturally occurring form, is characterized by being reactive to monoclonal antibody III.A4, having an apparent molecular weight of approximately 120-150 kD in its glycosylated form, and having the N-terminal amino acid sequence E L I P Q P.
    Type: Grant
    Filed: September 18, 1996
    Date of Patent: February 1, 2000
    Assignee: Amrad Corporation Limited
    Inventors: Andrew W. Boyd, Richard Simpson, Ian Wicks, Larry David Ward, David Wilkinson
  • Method of screening for ligands to a receptor-type tyrosine kinase
    Patent number: 5674691
    Abstract: The present invention relates to a method of screening for ligands to a receptor-type tyrosine kinase. The receptor-type tyrosine, in its naturally occurring form, is characterized by being reactive to monoclonal antibody III.A4, having an apparent molecular weight of approximately 120-150 kD in its glycosylated form, and having the N-terminal amino acid sequence E L I P Q P.
    Type: Grant
    Filed: April 18, 1994
    Date of Patent: October 7, 1997
    Assignee: Amrad Corporation Limited
    Inventors: Andrew W. Boyd, Richard John Simpson, Ian Wicks, Larry David Ward, David Wilkinson